المؤلفون: Jing, Changqin, Guo, Menglong, Bao, Xiaodan, Li, Tianhan, Lin, Juntang, Lu, Xinjie, Wang, Wenfeng

المساهمون: Science and Technology Foundation of Henan Province, China

المصدر: Cardiovascular Therapeutics ; volume 35, issue 5 ; ISSN 1755-5914 1755-5922

الإتاحة: https://doi.org/10.1111/1755-5922.12282Test

المؤلفون: Changqin Jing, Lu Xinjie, Bao Xiaodan, Li Tianhan, Guo Menglong, Wang Wenfeng, Juntang Lin

المصدر: Cardiovascular Therapeutics. 35:e12282

مصطلحات موضوعية: Lipopolysaccharides, 0301 basic medicine, medicine.medical_specialty, Nitric Oxide Synthase Type III, Lipopolysaccharide, Anti-Inflammatory Agents, Down-Regulation, 030204 cardiovascular system & hematology, Umbilical vein, miR-155, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Enos, Internal medicine, Human Umbilical Vein Endothelial Cells, medicine, Humans, Pharmacology (medical), RNA, Messenger, Endothelial dysfunction, Pitavastatin, Cells, Cultured, Pharmacology, Messenger RNA, Dose-Response Relationship, Drug, biology, business.industry, General Medicine, medicine.disease, biology.organism_classification, Molecular biology, Blot, MicroRNAs, 030104 developmental biology, Endocrinology, chemistry, Enzyme Induction, Quinolines, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945719e26b9640fa9b8be63a7ddca5d6Test
https://doi.org/10.1111/1755-5922.12282Test